Sagespring Wealth Partners, LLC Novo Nordisk A S Transaction History
Sagespring Wealth Partners, LLC
- $3.96 Trillion
- Q1 2025
A detailed history of Sagespring Wealth Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Sagespring Wealth Partners, LLC holds 18,036 shares of NVO stock, worth $1.25 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
18,036
Previous 19,344
6.76%
Holding current value
$1.25 Million
Previous $1.66 Billion
24.73%
% of portfolio
0.03%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,817Shares Held
339MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC18.8MShares$1.3 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.07 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$898 Million1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$874 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$844 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $156B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...